Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Prostate cancer gets first gene-targeted medicines
The Institute of Cancer Research, London, has strongly welcomed the approval by the US Food and Drug Administration (FDA) of the genetically targeted drug olaparib for some men with advanced prostate cancer.
Thousands of lives could be lost to delays in cancer surgery during COVID-19 pandemic
Delays to cancer surgery and other treatment caused by the coronavirus crisis could result in thousands of additional deaths linked to the pandemic in England, a major new study reports.
Mapping how evolutionary forces affect cancer growth could help doctors choose biopsies
A computer model that uses the principles of evolution to map the growth of populations of cancer cells in tumours could help doctors choose where to take biopsies from tumours, improving decisions about treatment.
New life-sciences incubator space plans announced for The London Cancer Hub
Life-science companies will have the opportunity to work directly alongside world-class scientists from The Institute of Cancer Research, London, after exciting plans were revealed to create a new innovation centre.
Scientists bring together world’s coronavirus research in 'intelligent' online database
Scientists have created a dynamic database driven by artificial intelligence which is collecting together the world’s research on coronavirus in a single online space.
Approval of targeted therapies first line for prostate cancer ‘will ease COVID-19 pressures’
The Institute of Cancer Research, London, has broadly welcomed the approval of targeted hormone therapies enzalutamide and abiraterone as first-line NHS treatments for men with advanced prostate cancer.
One-week course of radiotherapy could benefit women with early stage breast cancer, study finds
A one-week course of radiotherapy in fewer but larger daily doses was found to be as safe and effective as standard three-week therapy for women following surgery for early stage breast cancer. The protocol is being eagerly sought by hospitals to help reduce demands on the NHS during the COVID-19 pandemic.
Major trial shows breast cancer drug can hit prostate cancer Achilles heel
A drug already licensed for the treatment of breast and ovarian cancers is more effective than targeted hormone therapy at keeping cancer in check in some men with advanced prostate cancer, a major clinical trial reports.
Training for a marathon in a pandemic: the fundraisers helping us finish cancer
As sports events around the world are put on hold in the midst of the coronavirus crisis, Joanne Duffy finds out how #teamICR have come together to support each other, adapt their training and focus on what really matters to them.
Our COVID-19 research and how we’re supporting the NHS
Staff and students from across The Institute of Cancer Research, London, are using their scientific and clinical expertise as part of the national response to the coronavirus pandemic.
Scientists enhance new way to overcome resistance to targeted cancer treatments
Researchers have enhanced a new method for inhibiting the protein HSP72, known to be important in helping cancer cells survive and resist treatment, which will help scientists move closer to discovering a new cancer drug that targets the protein.
Babies with brain tumours could benefit from targeted treatment
Brain cancer in infants is biologically distinct from other childhood brain tumours and could be successfully treated with targeted drugs, a new study has shown.